By
Temasek emerges as the frontrunner to buy stake in Intas Pharma from ChrysCap

Singapore’s sovereign fund Temasek Holdings has emerged as the front runner in the race to acquire a little over 10 per cent stake in Ahmedabad-based Intas Pharmaceuticals from existing private ...

TO READ THE FULL STORY


Leave Your Comment(s)